Presented with collaborator Pfizer updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec, a gene therapy product ...
https://www.google.com/url?rct=j&sa=t&url=https://www.businesswire.com/news/home/20210224005277/en/Sangamo-Therapeutics-Reports-Recent-Business-Highlights-and-Fourth-Quarter-and-Full-Year-2020-Financial-Results&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNExjp8-8eZuUn7bCg0FGmKQ9NjEEQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.